Drug Database
BC
BCG polysaccharide and nucleic acid injection (intramuscular) (Disu / DI SU)
✓ Approved3SBio · Cell-based Therapies · Cell-based Therapies
What is BCG polysaccharide and nucleic acid injection (intramuscular)?
BCG polysaccharide and nucleic acid injection (intramuscular) is a cell-based therapies developed by 3SBio. It is approved for therapeutic indications via injectable (others) or intramuscular (im) injection.
Drug Profile
| Brand Names | Disu, DI SU |
| Company | 3SBio |
| Drug Class | Cell-based Therapies, Vaccine |
| Route | Injectable (Others), Intramuscular (IM) Injection |
| Status | Approved |
Sources: ClinicalTrials.gov, 3SBio
Therapeutic Indications
BCG polysaccharide and nucleic acid injection (intramuscular) is developed for 3 unique indications across 2 therapeutic areas.
| Therapeutic Area | Condition | Phase |
|---|---|---|
| Respiratory, thoracic and mediastinal disorders | Asthma | ✓ Approved |
| Respiratory, thoracic and mediastinal disorders | Bronchitis chronic | ✓ Approved |
| Infections and infestations | Rhinovirus infection | ✓ Approved |
Related Research Articles
Unable to load articles right now.